You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
兆科眼科-B(06622.HK):向國家藥監局取得供測量眼壓的TONO-i的醫療器械註冊證
格隆匯 08-04 17:47

格隆匯8月4日丨兆科眼科-B(06622.HK)發佈公吿,公司已向國家藥品監督管理局取得TONO-i的醫療器械註冊證。TONO-i為一款創新的眼壓計,設計特點為免觸式、便攜及輕便。有別於傳統的接觸式眼壓計,TONO-i可於無需麻醉下,無痛、無感染風險地安全使用。

TONO-i將作為公司旗下青光眼醫療產品組合的重要部分,滿足中國低診斷及治療比率的需求缺口。TONO-i為眼科醫生提供一種工具,透過測量輕易、準確及透徹地監察患者的眼壓,有助患者提供療效的即時及持續反饋,提高患者青光眼藥物治療的依從性。TONO-i加入公司的管線,標誌着公司在治療及診斷雙管齊下的青光眼管理承諾。

2022年11月,公司與C&VTech達成一項有關TONO-i的獨家分銷協議。C&VTech為一間於開發診斷、治療及預防青光眼的醫療器材領域具有領先地位的公司。根據該協議的條款,公司擁有於大中華登記、進口、推廣、分銷、營銷及出售TONO-i的獨家權利。該等權利其後透過合約修訂擴大至包括泰國及馬來西亞,自2024年8月起生效。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account